Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 3241-3254

  Xin, Wei ^a   Wanda, Soo Young ^a   Li, Yuhua ^a   Wang, Shifeng ^a   Mo, Hua ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BETA LACTAMASE; CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PROTEIN PSPA; PROTEIN PSPC; RECOMBINANT PROTEIN; SALMONELLOSIS VACCINE; SIGNAL PEPTIDE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; LIVE VACCINE; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCUS VACCINE; RECOMBINANT VACCINE; SPSA PROTEIN, STREPTOCOCCUS PNEUMONIAE;

ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENE VECTOR; IMMUNITY; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN SECRETION; PROTEIN SYNTHESIS; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MORTALITY; PHYSIOLOGY; PLASMID; SECRETION; STREPTOCOCCUS INFECTION; TIME;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BETA-LACTAMASES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; PLASMIDS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; TIME FACTORS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 46449130050     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01623-07     Document Type: Article

References (71)

1. Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
2. Bochkareva, E. S., M. E. Solovieva, and A. S. Girshovich. 1998. Targeting of GroEL to SecA on the cytoplasmic membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA 95:478-483.
3. Briles, D. E., S. K. Hollingshead, J. King, A. Swift, P. A. Braun, M. K. Park, L. M. Ferguson, M. H. Nahm, and G. S. Nabors. 2000. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182:1694-1701.
4. Briles, D. E., S. K. Hollingshead, G. S. Nabors, J. C. Paton, and A. Brooks-Walter. 2000. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19(Suppl. 1):S87-S95.
5. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
6. Brooks-Walter, A., D. E. Briles, and S. K. Hollingshead. 1999. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67:6533-6542.
7. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
8. Chen, L. M., G. Briones, R. O. Donis, and J. E. Galán. 2006. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun. 74:5826-5833.
9. Choi, J. H., and S. Y. Lee. 2004. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl. Microbiol. Biotechnol. 64:625-635.
10. Cianciotto, N. P. 2005. Type II secretion: a protein secretion system for all seasons. Trends Microbiol. 13:581-588.
11. Ciofu, O., T. J. Beveridge, J. Kadurugamuwa, J. Walther-Rasmussen, and N. Hoiby. 2000. Chromosomal β-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45:9-13.
12. Curtiss, R., III. 1965. Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J. Bacteriol. 89:28-40.
13. Curtiss, R., III, L. J. Charamella, C. M. Berg, and P. E. Harris. 1965. Kinetic and genetic analyses of D-cycloserine inhibition and resistance in Escherichia coli. J. Bacteriol. 90:1238-1250.
14. Curtiss, R., III, X. Zhang, S. Y. Wanda, H. Y. Kang, V. Konjufca, Y. Li, B. Gunn, S. Wang, G. Scarpellini, and I. S. Lee. 2007. Induction of host immune responses using Salmonella-vectored vaccines, p. 297-313. In K. A. Brogden, N. Cornick, T. B. Stanton, Q. Zhang, L. K. Nolan, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington, DC.
15. Curtiss, R., III, S. M. Kelly, and J. O. Hassan. 1993. Live oral avirulent Salmonella vaccines. Vet. Microbiol. 37:397-405.
16. Curtiss, R., III, S. M. Kelly, S. A. Tinge, C. O. Tacket, M. M. Levine, J. Srinivasan, and M. Koopman. 1994. Recombinant Salmonella vectors in vaccine development. Dev. Biol. Stand. 82:23-33.
17. Curtiss, R., III, K. Nakayama, and S. M. Kelly. 1989. Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo. Immunol. Investig. 18:583-596.
18. Curtiss, R., III, S.-Y. Wanda, X. Zhang, and B. Gunn. 2007. Salmonella vaccine vectors displaying regulated delayed in vivo attenuation to enhance immunogenicity, abstr. E-061, p 278. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
19. Curtiss, R., III. 2005. Antigen delivery systems: development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccines, p. 1009-1037. In J. Mestecky, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer (ed.), Mucosal immunology, 3rd ed., vol. 1. Academic Press, San Diego, CA.
20. Dodt, J., T. Schmitz, T. Schafer, and C. Bergmann. 1986. Expression, secretion and processing of hirudin in E. coli using the alkaline phosphatase signal sequence. FEBS Lett. 202:373-377.
21. Doggett, T. A., and R. Curtiss III. 1992. Delivery of antigens by recombinant avirulent Salmonella strains. Adv. Exp. Med. Biol. 327:165-173.
22. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 1998. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect. Immun. 66:732-740.
23. Dvorak, H. F., B. K. Wetzel, and L. A. Heppel. 1970. Biochemical and cytochemical evidence for the polar concentration of periplasmic enzymes in a "minicell" strain of Escherichia coli. J. Bacteriol. 104:543-548.
24. Galan, J. E., K. Nakayama, and R. Curtiss III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35.
25. Gentschev, I., I. Glaser, W. Goebel, D. J. McKeever, A. Musoke, and V. T. Heussler. 1998. Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infect. Immun. 66:2060-2064.
26. Gentschev, I., H. Mollenkopf, Z. Sokolovic, J. Hess, S. H. Kaufmann, and W. Goebel. 1996. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179:133-140.
27. Ghrayeb, J., H. Kimura, M. Takahara, H. Hsiung, Y. Masui, and M. Inouye. 1984. Secretion cloning vectors in Escherichia coli. EMBO J. 3:2437-2442.
28. Greenwood, B. 1999. The epidemiology of pneumococcal infection in children in the developing world. Philos. Trans. R. Soc. Lond. B 354:777-785.
29. Hennequin, C., F. Porcheray, A. Waligora-Dupriet, A. Collignon, M. Barc, P. Bourlioux, and T. Karjalainen. 2001. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 147:87-96.
30. Hess, J., I. Gentschev, D. Miko, M. Welzel, C. Ladel, W. Goebel, and S. H. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458-1463.
31. Hess, J., L. Grode, I. Gentschev, J. Fensterle, G. Dietrich, W. Goebel, and S. H. Kaufmann. 2000. Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination. Microbes Infect. 2:1799-1806.
32. Hollingshead, S. K., R. Becker, and D. E. Briles. 2000. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68:5889-5900.
33. Hopkins, S., J. P. Kraehenbuhl, F. Schödel, A. Potts, D. Peterson, P. de Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
34. Iannelli, F., M. R. Oggioni, and G. Pozzi. 2002. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 284:63-71.
35. Jonda, S., M. Huber-Wunderlich, R. Glockshuber, and E. Mossner. 1999. Complementation of DsbA deficiency with secreted thioredoxin variants reveals the crucial role of an efficient dithiol oxidant for catalyzed protein folding in the bacterial periplasm. EMBO J. 18:3271-3281.
36. Kaderbhai, M. A., C. C. Ugochukwu, D. C. Lamb, and S. L. Kelly. 2000. Targeting of active human cytochrome P4501A1 (CYP1A1) to the periplasmic space of Escherichia coli. Biochem. Biophys. Res. Commun. 279:803-807.
37. Kadonaga, J. T., A. Pluckthun, and J. R. Knowles. 1985. Signal sequence mutants of β-lactamase. J. Biol. Chem. 260:16192-16199.
38. Kang, H. Y., and R. Curtiss III. 2003. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 37:99-104.
39. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
40. Karamyshev, A. L., Z. N. Karamysheva, A. V. Kajava, V. N. Ksenzenko, and M. A. Nesmeyanova. 1998. Processing of Escherichia coli alkaline phosphatase: role of the primary structure of the signal peptide cleavage region. J. Mol. Biol. 277:859-870.
41. Kaufmann, S. H., and J. Hess. 1999. Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development. Immunol. Lett. 65:81-84.
42. Khokhlova, O. V., and M. A. Nesmeianova. 2003. Interaction of SecB and SecA with the N-terminal region of mature alkaline phosphatase on its secretion in Escherichia coli. Mol. Biol. (Moscow) 37:712-718.
43. Kochi, S. K., K. P. Killeen, and U. S. Ryan. 2003. Advances in the development of bacterial vector technology. Expert Rev. Vaccines 2:31-43.
44. Konjufca, V., S. Y. Wanda, M. C. Jenkins, and R. Curtiss III. 2006. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect. Immun. 74:6785-6796.
45. Koshland, D., and D. Botstein. 1980. Secretion of β-lactamase requires the carboxy end of the protein. Cell 20:749-760.
46. Kwon, H. Y., A. D. Ogunniyi, M. H. Choi, S. N. Pyo, D. K. Rhee, and J. C. Paton. 2004. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect. Immun. 72:5646-5653.
47. Lehnhardt, S., N. S. Pollitt, J. Goldstein, and M. Inouye. 1988. Modulation of the effects of mutations in the basic region of the OmpA signal peptide by the mature portion of the protein. J. Biol. Chem. 263:10300-10303.
48. Nayak, A. R., S. A. Tinge, R. C. Tart, L. S. McDaniel, D. E. Briles, and R. Curtiss III. 1998. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 66:3744-3751.
49. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-550.
50. Rentier-Delrue, F., D. Swennen, and J. Martial. 1988. pIN-III-ompA secretion vectors: modification of the ompA signal peptide sequence for easier insert cloning. Nucleic Acids Res. 16:8726.
51. Roberts, M., J. Li, A. Bacon, and S. Chatfield. 1998. Oral vaccination against tetanus: comparison of the immunogenicitres of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect. Immun. 66:3080-3087.
52. Saini, M., and S. Vrati. 2003. High-level synthesis of Johnson grass mosaic virus coat protein in Escherichia coli and its auto-assembly to form virus-like particles. Protein Expr. Purif. 28:86-92.
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
54. Schödel, F., S. Kelly, S. Tinge, S. Hopkins, D. Peterson, D. Milich, and R. Curtiss III. 1996. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization. Adv. Exp. Med. Biol. 397:15-21.
55. Sirard, J. C., F. Niedergang, and J. P. Kraehenbuhl. 1999. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol. Rev. 171:5-26.
56. Sletta, H., A. Tondervik, S. Hakvag, T. E. Aune, A. Nedal, R. Aune, G. Evensen, S. Valla, T. E. Ellingsen, and T. Brautaset. 2007. The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli. Appl. Environ. Microbiol. 73: 906-912.
57. Spellberg, B., and J. E. Edwards, Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:76-102.
58. Spreng, S., G. Dietrich, and G. Weidinger. 2006. Rational design of Salmonella-based vaccination strategies. Methods 38:133-143.
59. Stenstrom, C. M., E. Holmgren, and L. A. Isaksson. 2001. Cooperative effects by the initiation codon and its flanking regions on translation initiation. Gene 273:259-265.
60. Summers, R. G., and J. R. Knowles. 1989. Illicit secretion of a cytoplasmic protein into the periplasm of Escherichia coli requires a signal peptide plus a portion of the cognate secreted protein. Demarcation of the critical region of the mature protein. J. Biol. Chem. 264:20074- 20081.
61. Talmadge, K., and W. Gilbert. 1982. Cellular location affects protein stability in Escherichia coli. Proc. Natl. Acad. Sci. USA 79:1830-1833.
62. Tanji, Y., J. Gennity, S. Pollitt, and M. Inouye. 1991. Effect of OmpA signal peptide mutations on OmpA secretion, synthesis, and assembly. J. Bacteriol. 173:1997-2005.
63. Tinge, S. A., and R. Curtiss III. 1990. Isolation of the replication and partitioning regions of the Salmonella typhimurium virulence plasmid and stabilization of heterologous replicons. J. Bacteriol. 172:5266-5277.
64. Wang, S., Y. Li, G. Scarpellini, W. Kong, and R. Curtiss III. 2007. Salmonella vaccine vectors displaying regulated delayed antigen expression in vivo to enhance immunogenicity, abstr. E-064, p. 278. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
65. Witholt, B., M. Boekhout, M. Brock, J. Kingma, H. V. Heerikhuizen, and L. D. Leij. 1976. An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal. Biochem. 74:160-170.
66. Wu, H. Y., M. H. Nahm, Y. Guo, M. W. Russell, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846.
67. Xu, R., P. Du, J. J. Fan, Q. Zhang, T. P. Li, and R. B. Gan. 2002. High-level expression and secretion of recombinant mouse endostatin by Escherichia coli. Protein Expr. Purif. 24:453-459.
68. Yang, X., B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, R. Avci, and D. W. Pascual. 2007. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178:1059-1067.
69. Zekarias, B., H. Mo, and R. Curtiss III. 2008. Recombinant attenuated Salmonella enterica serovar Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin. Vaccine Immunol. 15:805-816.
70. Zhang, Q., J. Bernatoniene, L. Bagrade, A. J. Pollard, T. J. Mitchell, J. C. Paton, and A. Finn. 2006. Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur. J. Immunol. 36:46-57.
71. Zhang, X., S. M. Kelly, W. S. Bollen, and R. Curtiss III. 1997. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 Δcrp and Δcdt deletion mutants. Infect. Immun. 65:5381-5387.